Evidence map›Paper›PMID 28851448›Full record

ArticleAlzheimer's research & therapy2017

Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA

Mélanie H Thomas, Cédric Paris, Mylène Magnien, Julie Colin, Sandra Pelleïeux, Florence Coste, Marie-Christine Escanyé, Thierry Pillot, Jean-Luc Olivier

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Lipids and Secretory Vesicle Exocytosis.Advances in neurobiology · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mélanie H ThomasResearch unit on Animals and Functionality of Animal Products (URAFPA), Lorraine University, EA 3998, USC INRA 0340, 2, Avenue de la Forêt de Haye, TSA40602, F-54518, Vandœuvre-lès-Nancy, France.
Cédric ParisLaboratory of Biomolecules Engineering (LIBio), Lorraine University, 2, Avenue de la Forêt de Haye, TSA40602, F-54518, Vandœuvre-lès-Nancy, France.
Mylène MagnienResearch unit on Animals and Functionality of Animal Products (URAFPA), Lorraine University, EA 3998, USC INRA 0340, 2, Avenue de la Forêt de Haye, TSA40602, F-54518, Vandœuvre-lès-Nancy, France.
Julie ColinResearch unit on Animals and Functionality of Animal Products (URAFPA), Lorraine University, EA 3998, USC INRA 0340, 2, Avenue de la Forêt de Haye, TSA40602, F-54518, Vandœuvre-lès-Nancy, France.
Sandra PelleïeuxResearch unit on Animals and Functionality of Animal Products (URAFPA), Lorraine University, EA 3998, USC INRA 0340, 2, Avenue de la Forêt de Haye, TSA40602, F-54518, Vandœuvre-lès-Nancy, France.
Florence CosteResearch unit on Animals and Functionality of Animal Products (URAFPA), Lorraine University, EA 3998, USC INRA 0340, 2, Avenue de la Forêt de Haye, TSA40602, F-54518, Vandœuvre-lès-Nancy, France.
Marie-Christine EscanyéBiochemistry Department, Central Hospital, University Hospitals of Nancy, 24, avenue du Mal de Lattre de Tassigny, CO n°34, F-54018, Nancy, France.
Thierry PillotSynaging SAS, 2, rue du Doyen Marcel Roubault, 54518, Vandoeuvre-les-Nancy, France.
Jean-Luc OlivierResearch unit on Animals and Functionality of Animal Products (URAFPA), Lorraine University, EA 3998, USC INRA 0340, 2, Avenue de la Forêt de Haye, TSA40602, F-54518, Vandœuvre-lès-Nancy, France. jean-luc.olivier@univ-lorraine.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolyunsaturated fatty acids play a crucial role in neuronal function, and the modification of these compounds in the brain could have an impact on neurodegenerative diseases such as Alzheimer's disease. Despite the fact that arachidonic acid is the second foremost polyunsaturated fatty acid besides docosahexaenoic acid, its role and the regulation of its transfer and mobilization in the brain are poorly known.

methodsTwo groups of 39 adult male BALB/c mice were fed with an arachidonic acid-enriched diet or an oleic acid-enriched diet, respectively, for 12 weeks. After 10 weeks on the diet, mice received intracerebroventricular injections of either NaCl solution or amyloid-β peptide (Aβ) oligomers. Y-maze and Morris water maze tests were used to evaluate short- and long-term memory. At 12 weeks on the diet, mice were killed, and blood, liver, and brain samples were collected for lipid and protein analyses.

resultsWe found that the administration of an arachidonic acid-enriched diet for 12 weeks induced short-term memory impairment and increased deleterious effects of Aβ oligomers on learning abilities. These cognitive alterations were associated with modifications of expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, postsynaptic density protein 95, and glial fibrillary acidic protein in mouse cortex or hippocampus by the arachidonic acid-enriched diet and Aβ oligomer administration. This diet also led to an imbalance between the main ω-6 fatty acids and the ω-3 fatty acids in favor of the first one in erythrocytes and the liver as well as in the hippocampal and cortical brain structures. In the cortex, the dietary arachidonic acid also induced an increase of arachidonic acid-containing phospholipid species in phosphatidylserine class, whereas intracerebroventricular injections modified several arachidonic acid- and docosahexaenoic acid-containing species in the four phospholipid classes. Finally, we observed that dietary arachidonic acid decreased the expression of the neuronal form of acyl-coenzyme A synthetase 4 in the hippocampus and increased the cytosolic phospholipase A

conclusionsDietary arachidonic acid could amplify Aβ oligomer neurotoxicity. Its consumption could constitute a risk factor for Alzheimer's disease in humans and should be taken into account in future preventive strategies. Its deleterious effect on cognitive capacity could be linked to the balance between arachidonic acid-mobilizing enzymes.

Indexed as

Amyloid beta-PeptidesAnimalsArachidonic AcidAstrocytesCell ProliferationCerebral CortexCoenzyme A LigasesCytosolDietDisks Large Homolog 4 ProteinHippocampusMaleMaze LearningMemory DisordersMice, Inbred BALB CNeuronsAcsl4 protein, mouseAmyloid beta-Peptidesamyloid beta-protein (1-42)Arachidonic AcidCoenzyme A LigasesDisks Large Homolog 4 ProteinDlg4 protein, mouseOleic AcidPeptide FragmentsPhospholipases A2Receptors, AMPAAcyl-CoA synthetase 4Alzheimer’s diseaseAMPA receptorsAmyloid-β oligomersArachidonic acidCytosolic phospholipase A2DietPhospholipid species

Identifiers

PMID28851448
PMCPMC5576249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.